Ebrahimzadeh Azadeh, Pagheh Abdol Sattar, Mousavi Tahoora, Fathi Maryam, Moghaddam Sayyed Gholamreza Mortazavi
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Molecular and Cell Biology Research Center (MCBRC), Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
J Clin Tuberc Other Mycobact Dis. 2023 Feb 23;31:100354. doi: 10.1016/j.jctube.2023.100354. eCollection 2023 May.
Tuberculosis (TB) is among the most common cause of serositis. There are many uncertainties in diagnostic and therapeutic approach to serous membranes tuberculosis. Our aim in the present review is to discuss the regional facilities for timely diagnosis, rapid decision-making and appropriate treatment regarding to serous membranes tuberculosis; with emphasis on situation in Iran. A comprehensive literature searches about the status of serous membranes tuberculosis in Iran were performed in English databases including Google Scholar, Science Direct, Scopus, Pub Med, and Web of Sciences, Persian SID databases, between 2000 and 2021. The main findings of the present review are as follow: a) pleural tuberculosis is more common than pericardial or peritoneal tuberculosis. b) Clinical manifestations are non-specific and so non-diagnostic. c) Smear and culture, PCR and characteristic granulomatous reaction have been used for definitive TB diagnosis by physicians. d) With Adenosine Deaminase Assays and Interferon-Gamma Release Assays in mononuclear dominant fluid, a possible diagnosis of TB is proposed by experienced physicians in Iran. e) In area of endemic for tuberculosis including Iran, a possible diagnosis of TB is enough to begin empirical treatment. f) In patients with uncomplicated tuberculosis serositis, treatment is similar to pulmonary tuberculosis. First line drugs are prescribed unless evidence of MDR-TB is detected. g) The prevalence of drug resistant tuberculosis (MDR-TB) in Iran is between 1% and 6%, and are treated by empirical standardized treatment. h) It is not known whether adjuvant corticosteroids are effective in preventing long term complication. i) Surgery may be recommended for MDR-TB. Tamponade or constrictive pericarditis and intestinal obstruction. In conclusion, it is recommended to consider serosal tuberculosis in patients who have unknown mononuclear dominant effusion and prolonged constitutional symptoms. Experimental treatment with first line anti-TB drugs can be started based on possible diagnostic findings.
结核病(TB)是浆膜炎最常见的病因之一。浆膜结核的诊断和治疗方法存在许多不确定性。本综述的目的是讨论关于浆膜结核及时诊断、快速决策和适当治疗的区域设施;重点关注伊朗的情况。在2000年至2021年期间,在包括谷歌学术、科学Direct、Scopus、PubMed和科学网在内的英文数据库以及波斯语SID数据库中,对伊朗浆膜结核的现状进行了全面的文献检索。本综述的主要发现如下:a)胸膜结核比心包结核或腹膜结核更常见。b)临床表现是非特异性的,因此无法诊断。c)涂片和培养、PCR以及特征性肉芽肿反应已被医生用于确诊结核病。d)在单核细胞占主导的积液中进行腺苷脱氨酶检测和干扰素-γ释放检测后,伊朗经验丰富的医生提出了结核病的可能诊断。e)在包括伊朗在内的结核病流行地区,结核病的可能诊断足以开始经验性治疗。f)在患有非复杂性结核性浆膜炎的患者中,治疗与肺结核相似。除非检测到耐多药结核病的证据,否则开具一线药物。g)伊朗耐多药结核病(MDR-TB)的患病率在1%至6%之间,并通过经验性标准化治疗进行治疗。h)辅助性皮质类固醇是否能有效预防长期并发症尚不清楚。i)对于耐多药结核病、心包填塞或缩窄性心包炎以及肠梗阻,可能建议进行手术。总之,对于有不明原因的单核细胞占主导的积液和长期全身症状的患者,建议考虑浆膜结核。可根据可能的诊断结果开始使用一线抗结核药物进行试验性治疗。